Paper Details

  1. Home
  2. Paper Details

Predictors of short-term treatment response in 66 patients with panic disorder.

Author: BlackD W, BowersW, GabelJ, MonahanP, WesnerR B

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

In a study of 66 people with panic disorder, fluvoxamine, a type of medication, was effective in reducing panic symptoms within three weeks. Those with less severe panic attacks and without a personality disorder showed the best response to treatment. Personality disorders were a negative predictor of success with cognitive therapy.
Paper Details　
Original Abstract of the Article :
Short-term treatment response in panic disorder was studies in 66 subjects who had completed 3 weeks of treatment with fluvoxamine (n = 23), cognitive therapy (n = 20), or placebo (n = 23). Clinical and self-rated assessments were gathered at baseline, during, and after treatment. Using multiple log...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0165-0327(94)90131-7

データ提供：米国国立医学図書館（NLM）

Predicting Treatment Response in Panic Disorder

This research delves into the realm of [Mental Health Treatment], focusing on the short-term treatment response in patients with panic disorder. The study compared the effectiveness of fluvoxamine, cognitive therapy, and placebo in reducing panic symptoms. The findings suggest that fluvoxamine and a low panic attack severity score are important predictors of successful treatment.

Factors Influencing Panic Disorder Treatment Success

This study identifies several factors that contribute to successful treatment for panic disorder. The findings suggest that fluvoxamine, a lower severity of panic attacks, and the absence of a comorbid personality disorder are associated with a higher likelihood of positive treatment outcomes.

Seeking Effective Treatment for Panic Disorder

Just like a camel navigating a desert needs to find a reliable oasis, individuals with panic disorder require effective treatment to find relief from their symptoms. This research emphasizes the importance of tailoring treatment strategies based on individual factors, including symptom severity and the presence of comorbid conditions.

Dr. Camel's Conclusion

This research underscores the importance of individual factors in predicting treatment response for panic disorder. The study highlights the potential benefits of fluvoxamine and the need for careful consideration of comorbid conditions. These findings encourage further research to optimize treatment approaches for individuals with panic disorder and promote improved mental well-being.

Date :
  1. Date Completed 1994-07-22
  2. Date Revised 2019-09-04
Further Info :

Pubmed ID

8014323

DOI: Digital Object Identifier

10.1016/0165-0327(94)90131-7

Related Literature

Article Analysis
・Effective treatment of panic disorder
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.